HealthUS FDA approves Asahi Kasei drug for persistent herpes infections

The US FDA approved a drug from Japan's Asahi Kasei on Friday for persistent herpes simplex virus sores in certain immunocompromised patients who have not responded to available antiviral treatments.

drug approvalherpesAsahi Kasei

RReuters★★★☆☆2026-10-09 19:45Original